Clostridial agents cannot be eradicated because they are universally present in soil and the intestinal tract of cattle. They produce potent toxins that can result in death of otherwise healthy animals, often with great speed.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens types B,C, & D.
Clostridial agents cannot be eradicated because they are universally present in soil and the intestinal tract of cattle. They produce potent toxins that can result in death of otherwise healthy animals, often with great speed.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens types B,C, & D.
Vaccination of healthy cattle and calves as an aid in preventing disease caused by Haemophilus somnus (a major contributor to respiratory disease and cause of thrombotic meningoencephalitis (TEME) and reproductive tract infection)
Contains three inactivated isolates of H. somnusfrom respiratory, reproductive, and nervous tissue.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis -Cl. perfringens types B, C, and D.
Use as an aid in preventing bacillary hemoglobinuria caused by Cl. haemolyticum.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis -Cl. perfringens types B, C, and D.
Use as an aid in preventing bacillary hemoglobinuria caused by Cl. haemolyticum.
3-Way live virus for the vaccination of healthy cattle against IBR, BVD, and Type I and II (BVD).
Inject 2 mL sub-Q or IM. Annual revaccination is recommended. If vaccinated prior to weaning, repeat 30 days after weaning when the possible influence of maternal antibodies is decreased.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.